HIGHLIGHTS
- who: Impaired Glucose Tolerance and colleagues from the Cardiology, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy, Endocrinology, Department of Internal Medicine and Biomedical have published the paper: Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance, in the Journal: PLOS ONE | www.plosone.org of September/21,/2012
- what: The aim of the study was to evaluate whether the addition of pioglitazone in_vitro can prove benefit in EPC obtained from IGT subjects in terms of apoptosis, viability and tube formation capacity. In this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.